1. Home
  2. RKDA vs GTBP Comparison

RKDA vs GTBP Comparison

Compare RKDA & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcadia Biosciences Inc.

RKDA

Arcadia Biosciences Inc.

HOLD

Current Price

$2.04

Market Cap

3.0M

Sector

Industrials

ML Signal

HOLD

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$0.84

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RKDA
GTBP
Founded
2002
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
2.6M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
RKDA
GTBP
Price
$2.04
$0.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.7K
2.0M
Earning Date
11-07-2025
02-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,173,000.00
N/A
Revenue This Year
$21.31
N/A
Revenue Next Year
$28.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.31
N/A
52 Week Low
$1.76
$0.54
52 Week High
$6.71
$3.85

Technical Indicators

Market Signals
Indicator
RKDA
GTBP
Relative Strength Index (RSI) 25.70 57.23
Support Level $1.76 $0.75
Resistance Level $3.50 $0.94
Average True Range (ATR) 0.30 0.08
MACD -0.18 0.01
Stochastic Oscillator 16.18 64.47

Price Performance

Historical Comparison
RKDA
GTBP

About RKDA Arcadia Biosciences Inc.

Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: